AU Patent

AU2019225031B2 — Powder preparation, cartridge, and device

Assigned to Shin Nippon Biomedical Laboratories Ltd · Expires 2024-04-18 · 2y expired

What this patent protects

The present invention addresses the problem of providing: a powdery preparation suitable for the selective administration to an olfactory region or the like; and others. The problem can be solved by a powdery preparation which contains an active ingredient and can be used for the…

USPTO Abstract

The present invention addresses the problem of providing: a powdery preparation suitable for the selective administration to an olfactory region or the like; and others. The problem can be solved by a powdery preparation which contains an active ingredient and can be used for the selective administration of the active ingredient to an olfactory region in the nasal cavity, wherein the bulk density of the powdery preparation is 0.1 to 0.5 g/cm

Drugs covered by this patent

Patent Metadata

Patent number
AU2019225031B2
Jurisdiction
AU
Classification
—
Expires
2024-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Shin Nippon Biomedical Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.